MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE STUDY WITH THE REFERENCE PRODUCTS, FOR ASSESSMENT OF THERAPEUTIC SUPERIORITY OF THE COMBINATION CLINDAMYCIN-TRETINOIN/VERISFIELD, GEL, (1.0+0.025)%, (VERSUS THE MONOTHERAPY WITH CLINDAMYCIN OR TRETINOIN) FOR THE TOPICAL TREATMENT OF ACNE.

Trial Profile

MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE STUDY WITH THE REFERENCE PRODUCTS, FOR ASSESSMENT OF THERAPEUTIC SUPERIORITY OF THE COMBINATION CLINDAMYCIN-TRETINOIN/VERISFIELD, GEL, (1.0+0.025)%, (VERSUS THE MONOTHERAPY WITH CLINDAMYCIN OR TRETINOIN) FOR THE TOPICAL TREATMENT OF ACNE.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Jan 2013

At a glance

  • Drugs Clindamycin/tretinoin (Primary) ; Clindamycin; Tretinoin
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Feb 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 22 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top